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Abstract 
Introduction: Diagnosis of neurofibroma usually is based on the specific morphology and 
arrangement of mesenchymal cells in routine Hematoxylin and Eosin (H&E) sections, and 
detection of mast cells supports the diagnosis. Sometimes definite diagnosis from other 
mesenchymal lesions may be difficult. The aim of the present study was to compare S100 
expression and mast cells count (as Gold Standard) with routine histopathologic diagnosis. 
Methods: In this cross-sectional analytical study, all cases of neurofibroma and compatible/ 
consistent with neurofibroma, that had been diagnosed in department of oral & maxillofacial 
pathology, school of dentistry, Shiraz, from 1986 to 2013, were enrolled. Immunohistochemistry 
was performed using S100 antibody and slides were stained by Giemsa. S100 labeling index, 
intensity and distribution as well as mast cells count were evaluated using light microscope. 
Results: Mast cells were present in 97% of cases that 56.4 % showed 1-200 cells/10HPF. 82 % of 
cases were positive for S100 that 40.7% showed 2-30% labeling index and 70.4% had moderate 
intensity for S100 staining. 
Conclusions: The comparison of routine histopathologic examination with gold standard method 
in Oral Pathology Department of Shiraz Dental School confirmed the routine histopathologic 
diagnosis in all cases, therefore no more evaluation may be required if a pathologist considers all 
routine diagnostic criteria. 
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 مقایسه استانذارد طلایی ضناسایی نوروفيبرومای دهانی با روش تطخيص 
 هيستوپاتولوشیک رایج در بخص پاتولوشی دانطکذه دنذانپسضکی ضيراز
 
  *ضاملو، زینب منيری نفيسه، زهره جعفری اضکونذی، ناشوانیدهقانی  علی
 
 چکيذه
ي مطبَذٌ ی مًرفًلًصی ي  )E&H( ز پبیٍ روگ آمیشی َمبتًکسیلیه ي ائًسیهتطخیع وًريفیبزيمب بٍ غًرت معمًل ب :مقذمه
آرایص خبظ سلًل َبی مشاوطیمی درکىبر بزرسی يجًد مبست سل َب غًرت می پذیزد. گُگبٌ بب تًجٍ بٍ اضتزاکبت ومبَبی 
ومی تًان تطخیع وًريفیبزيمب  َیستًلًصیک در ضبیعبت مختلفی کٍ در تطخیع افتزاقی وًريفیبزيمب مطزح می ضًوذ بٍ طًر قطعی
ي بزرسی مبست سل َب بٍ عىًان استبوذارد طلایی تطخیع بب ريش رایج  001Sرا تبییذ ومًد، َذف ایه مطبلعٍ مقبیسٍ بیبن وطبوگز 
 تطخیع بًدٌ است.
ًلًصی دَبن ي مقطعی، بلًک َبی مزتبط بب تمبمی پزيوذٌ َبی مًجًد در بخص پبت-در ایه مطبلعٍ ی تحلیلی مواد و روش ها:
 ،E&Hبز اسبس روگ آمیشی 2931تب  5631فک ي غًرت داوطکذٌ دوذاوپشضکی ضیزاس کٍ تطخیع َیستًپبتًلًصیک آن َب اس سبل 
وًريفیبزيمب يیب مىطبق بز وًريفیبزيمب بًدٌ است، اس آرضیً بخص استخزاج گزدیذ. سپس لام َب بب روگ آمیشی گیمسب ي 
بب استفبدٌ اس میکزيسکًپ وًری، ضمبرش مبست سل َب ي میشان، ضذت ي تًسیع روگ پذیزی  روگ ضذوذ. 001S ایمىًَیستًضیمی
 مًرد ارسیببی قزار گزفت. 001S
وفز)، 81% مًارد ( 65/4% ومًوٍ َب حضًر مبست سل َب تبییذ ضذ کٍ میشان حضًر آن َب در79ومًوٍ مًجًد، در  33اس بیه یافته ها: 
ثبت گزدیذ. اس میبن ومًوٍ َبی   dleif rewop hgiH)FPHکزيسکًپی بب بشرگىمبیی ببلا (فیلذ می 01سلًل در  002کمتز اس 
 03تب  2وفز)  11% بیمبران (04/7روگ گزفتىذ کٍ میشان روگ پذیزی سلًل َب در  001S% بیمبران بٍ يسیلٍ ی مبرکز 28مًجًد 
 ًسط بًد. وفز)، مت 91% بیمبران ( 07/4در  001Sدرغذ ي ضذت روگ پذیزی آن َب بب 
روگ آمیشی َبی استبوذارد طلایی ي مقبیسٍ ی دي ريش درگزيٌ پبتًلًصی دَبن داوطکذٌ دوذاوپشضکی ضیزاس مًیذ  نتيجه گيری:
ي استبوذاردَبی طلایی در تمبمی ومًوٍ َب بًد کٍ ایه وطبن می دَذ در  E&Hَمبَىگی میبن تطخیع َیستًپبتًلًصیک رایج بب 
مبمی معیبر َبی تطخیػی رایج را در وظز بگیزد، احتمبلا دیگز ویبس بٍ غزف َشیىٍ ي سمبن بیطتز بزای کٍ یک پبتًلًصیست تغًرتی
 تبییذ آن َب بب استبوذارد طلایی يجًد وخًاَذ داضت.
 ، روگ آمیشی گیمسب، مبست سل001-Sوًريفیبزيمب، پزيتئیه  واشگان كليذی:
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can show S100 protein in the most cases of 
neurofibroma which confirms the diagnosis.
[2,3]
  
In Karvonen et al. study (2000), S100 was used as 
the gold standard for identification of new tumors in 
patients with neurofibromatosis type1.
[14]
  
Karamchandani et al. used S100 for detection of 
cells with nervous system origin in soft tissue 
neoplasms.
[15]
 Diagnosis of neurofibroma usually is 
based on the specific morphology and arrangement of 
mesenchymal cells in routine H&E sections, and 
detection of mast cells supports the diagnosis. 
Sometimes definite diagnosis from other mesenchymal 
lesions may be difficult because of similarity in 
histopathologic features and the mast cells may not be 
detected.  
Furthermore, the researchers found no research on 
comparison between the common H&E method and 
S100 and Giemsa staining to evaluate the accuracy 
level of neurofibroma diagnosis. Therefore, the aim of 
the present study was to compare S100 positivity and 
mast cells detection as gold standards with routine 
histopathologic diagnosis. 
 
 
Methods 
In this cross-sectional analytical study, all cases of 
neurofibroma and those compatible/consistent with 
neurofibroma that had been diagnosed in department of 
oral & maxillofacial pathology School of Dentistry of 
Shiraz, between 1986 to 2013 were enrolled.  
The diagnosis was confirmed by pathologists 
according to routine histopathologic features. All cases 
had enough tissue for evaluation. For S100 and mast 
cell, staining two sections with 4-µm thickness was 
provided. For Giemsa staining, the sections were 
deparaffinized and were placed in 5% Giemsa solution 
for one hour, then washed with acid acetic and water. 
Finally the sections were mounted and evaluated using 
light microscope.
[16]  
Mast cell count was evaluated in 10 microscopic 
fields, at 400 magnification and reported as negative 
(0), +positive (1-200), ++positives (between 200-1000) 
and +++positives (>1000). S100 expression was 
evaluated by immunohistochemistry.
[16] 
The sections 
were deparaffinized and rehydrated.  
Endogenous peroxidase activity was inhibited by 
3% H2O2. Then, the sections were incubated with 
S100, Polyclonal Rabbit antibody (Ready to use, code 
iR504-DakoLTD) for 30 minutes. 3, 
3_di_aminobenzidine (DAB-Code K8004-DAKO 
LTD) solution was used as chromogen. A section of 
schwannoma was used as positive control.  
Primary antibody was replaced by TBS Buffer in 
negative control sections.
[17]
 S100 expression was 
classified in 4 groups: negative (<2%), +positive(2-
30%), ++positives(30-80%), +++positives(>80%). 
Regarding to intensity of expression, the results were 
categorized in 3 grades: 1: low, 2: moderate, 3: 
intense.
[18] 
Data were analyzed using SPSS software 
version 11. 
 
 
Results 
33 cases of neurofibroma were evaluated. They 
were 16-74 years, with mean age of 50 years. 18 cases 
(54.5%) were male and 15 (45.5%) were female. 
Regarding to the location, neurofibroma was reported 
in gingival (42.4%), buccal mucosa (24.2%) and other 
areas such as retromolar pad, mandibular body, hard 
palate, tongue and floor of the mouth (33.4%). Giemsa 
staining demonstrated the mast cells as round, oval or 
polygonal cells with purple granules (figures 1&2).  
Mast cells were found in 97% of the cases, the 
mast cell count in 56.4% (18 patients) of the cases was 
found one positive (+), 21.8% (7 patients) two positive 
(++) and 21.8% (7 patients) three positive (+++).  
In S100 positive immunoreactions, mesenchymal 
cells were found with brown nucleus and cytoplasm 
(figure 3). S100 expression is shown in table 1.The 
diagnosis was confirmed in the cases that were positive 
for Giemsa, S100 or both of them (table 2). 
 
 
 
 
 
 
 
 
 
 
Figure1. Bundles of fusiform mesenchymal cells with  
elongated and wavy nuclei in a neurofibroma lesion 
beside the presence of mast cells (Asterisk) (H&E 
magnification, 400X( 
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 Giemsa and S100 immunostaining in oral neurofibroma 
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Figure2. Polygonal mast cells in a neurofibroma lesion 
with blue nuclei and basophilic abundant granules 
 in its cytoplasm (Giemsa staining, 1000 X) 
 
 
       
 
 
 
 
 
 
  
 Figure3. Brown S100 staining in nuclei and cytoplasm 
of mesenchymal cells with diffuse pattern  
(IHC staining, 400X) 
 
 
  
 
Table1. Quantity, intensity and distribution of S100 in neurofibroma cases 
 
Positive cases S100 staining S100 staining intensity 
Pattern of S100 
staining 
27 
1+ 2+ 3+ Grade1 Grade2 Grade3 focal diffuse 
11 9 7 4 19 4 12 15 
40.7% 33.4% 25.9% 14.8% 70.4% 14.8% 44.5% 55.5% 
 
 
Table2. Comparison of H&E staining with special staining methods in this study 
 
H&E diagnosis confirmation 
with both gold standards 
H&E diagnosis 
confirmation with s100 
H&E diagnosis confirmation 
with Giemsa 
Total 
cases 
33 27 32 
33 
100% 82% 97% 
 
Discussion 
Histopathologic features of all neurofibromas and 
the similar lesions in this study were interlacing 
fascicles of spindle-shaped cells with fusiform or wavy 
nuclei based on H&E sections (figure1) beside many 
mast cells scattered among them. 
[2]
 According to the 
study of Leclere et al. Giemsa staining for detection 
and confirmation of mast cells is considered more 
appropriate because it had manifested less expense and 
more convenient application among the other four 
staining methods. 
[5]
  
In this study, 97% of mast cells were stained by 
Giemsa and proved their existence in H&E slides 
(figure2). Their count also showed vast spectrum of 
their presence in neurofibroma lesions from less than 
200 cells/10HPF to more than 1000 cells/10HPF; 
56.4% of the cases were under 200 cell/10HPF, half of  
the remaining cases were from 200 to 1000 and half of 
the other had more than 1000 cells/10HPF. S100 
normally exists in nucleus and cytoplasm of cells 
derived from neural crest (schwann and gelial cells and 
melanocytes) and tumors derived from them.
[6,7,12,13]
 In 
the present study, the neural origin of the majority of 
the cases was confirmed by IHC staining for S100 
(82% of patients) (figure 3). In a study, 49 patients 
with peripheral nervous system tumors showed S100 
positivity in all neurofibroma cases
[18]
, while in another 
study, S100 was positive in 95% of the cases.
[15]  
Other study also showed S100 staining in about 
half of the skin tumors of 9 patients suffered from 
neurofibromatosis type1.
[14]
 The labeling index of S100 
in this study was 1 positive in 40.7% (11 patients), 2 
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positives in 33.4% (9 patients) and 3 positives in 
25.9% (7 patients) which suggests diversity in the 
quantity of S100 expression. As a result, it may not 
help in differential diagnosis of neural tumors although 
the confirmation of this issue needs more research. In 
the present study, the intensity of S100 staining was 
also reported the same as previous immuno-
histochemistry studies.  
Nevertheless, considering the fact that the staining 
intensity is a subjective matter and quantitative 
parameters are more significant in data analysis. The 
intensity was gradually eliminated from these studies 
and its report can only show staining errors.
[19,20]
 The 
evaluation of the S100 staining pattern can be helpful 
in the differential diagnosis of neural tumors too, as in 
the present study focal staining was observed in 44.5% 
of the patients and diffuse distribution in 55.5%. 
Ghilusi et al. stated that the focal pattern of S100 in all 
cases.
[18]
 Weiss and et al. reported S100 staining only 
in a group of cells because neurofibroma had different 
cellular population.  
Therefore, S100 staining is distributed in these 
lesions in various patterns.
[21]
 Karamchandani et al. 
also have compared S100 staining pattern in a number 
of soft tissue neoplasms except neurofibroma.
[15] 
Therefore, it is suggested to evaluate and compare 
staining patterns in studies with higher number of cases 
and in particular in those associated with neurofibroma 
and/or neural tumors. Taking into account the 
confirmation of mast cells in almost all H&E samples, 
and the positive results for S100 expression in 82% of 
the cases, this study proved the harmony between the 
current histopathologic diagnosis (H&E) and gold 
standards. In this study, 18% of the cases (6 patients) 
were reported negative for S100, considering re-
staining of negative cases beside positive controls 
throughout the procedure, so it is possible to associate 
this phenomenon to the absence of S100 expression in 
some neural tumors.  
Yet, expression of other neural markers is probable 
in these lesions. So for these cases, diagnosis of 
neurofibroma is confirmed to consider the morphology 
of cells and also the presence of mast cells in them, too. 
 
 
Conclusions 
Neurofibroma is a benign tumor with neural 
origin, its common diagnosis of which is based on 
H&E staining and the pathologists report this tumor 
when they detect interlacing fascicles of spindle-
shaped cells with fusiform or wavy nuclei and also the 
presence of mast cells. Gold standard staining and the 
comparison between the two methods in the present 
study showed that the current diagnosis was totally 
confirmed in Oral Pathology Department of Shiraz 
Dental School, therefore no more evaluation may be 
required for future cases if a pathologist considers all 
routine diagnostic criteria. 
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